TRMT6 also predicted poorer prognosis in glioma and promoted glioma cell proliferation, migration, and invasion by regulating cell cycle, MYC, TGF-β, PI3K-AKT, NOTCH, and MTORC1 pathways (Fig. 3c) [205]. Here, AKT1 is linked to central nervous system cancer.